MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Nov. 25, 2003--IMPAC Medical Systems, Inc. (NASDAQ:IMPC), a leading supplier of healthcare IT solutions for oncology and related specialties, will host a special conference call on Monday, December 1, 2003, at 7:00 AM (PT) to discuss the definitive asset purchase agreement entered into with IMPATH. Specific information regarding the definitive agreement has previously been released.

Individuals are invited to listen to the call by dialing 1-800-901-5231. International callers can dial 1-617-786-2961. The PIN number, 62237454, is the same for both domestic and international participants. The conference call can also be accessed live over the Internet through the IMPAC website, www.impac.com. Please go to the website at least 15 minutes early to register, download and install any necessary audio software. A replay on the Company website will be available for two weeks after the original broadcast.

About IMPAC Medical Systems

IMPAC Medical Systems, Inc. is a leading provider of specialized IT solutions that streamline both clinical and business operations to help improve the process of delivering quality patient care. With open integration to multiple healthcare data and imaging systems, IMPAC offers a comprehensive IT solution that includes specialized electronic charting, full-featured practice management, clinical laboratory management, and outcomes reporting. Supporting over 1500 installations worldwide, IMPAC delivers practical solutions that deliver better overall communication, process efficiency and quality patient care. For more information about IMPAC Medical Systems' products and services, please call 650-623-8800 or visit www.impac.com.

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities and Exchange Act of 1934, including statements regarding the Company's expectations, beliefs, hopes, intentions or strategies regarding the future. Forward-looking statements include statements regarding the Company's business strategy, timing of, and plans for, the introduction of new products and enhancements, future sales, market growth and direction, competition, market share, revenue growth, operating margins and profitability. All forward-looking statements included in this document are based upon information available to the Company as of the date hereof, and the Company assumes no obligation to update any such forward- looking statement. Actual results could differ materially from the Company's current expectations. Factors that could cause or contribute to such differences include the Company's ability to expand outside the radiation oncology market or expand into international markets, lost sales or lower sales prices due to competitive pressures, ability to integrate its products successfully with related products and systems in the medical services industry, reliance on distributors and manufacturers of oncology equipment to market its products, and other factors and risks discussed in the Company's 10K and other reports filed by the Company from time to time with the Securities and Exchange Commission.

    CONTACT: IMPAC Medical Systems, Inc.
             Kendra A. Borrego, 650-623-8870
             kborrego@impac.com

    SOURCE: IMPAC Medical Systems, Inc.